Equities

China Medical System Holdings Ltd

China Medical System Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)7.35
  • Today's Change-0.300 / -3.92%
  • Shares traded5.67m
  • 1 Year change-46.51%
  • Beta1.0962
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6,1435,8684,364
Total Receivables, Net1,8652,2312,330
Total Inventory638477473
Prepaid expenses149212213
Other current assets, total--420
Total current assets8,7948,8297,380
Property, plant & equipment, net1,4871,7811,320
Goodwill, net1,5481,6661,691
Intangibles, net2,2162,0662,216
Long term investments3,6153,3423,088
Note receivable - long term303062
Other long term assets--015
Total assets17,73117,75415,808
LIABILITIES
Accounts payable142178146
Accrued expenses281368464
Notes payable/short-term debt1,27000
Current portion long-term debt/capital leases151,7991,121
Other current liabilities, total341532350
Total current liabilities2,0492,8772,081
Total long term debt1713592
Total debt1,3021,8131,712
Deferred income tax109125124
Minority interest3614895
Other liabilities, total00.91164
Total liabilities2,2113,1643,055
SHAREHOLDERS EQUITY
Common stock848484
Additional paid-in capital2,1062,1062,154
Retained earnings (accumulated deficit)13,63812,58910,609
Treasury stock - common------
Unrealized gain (loss)(372)(242)(67)
Other equity, total6552(28)
Total equity15,52014,58912,752
Total liabilities & shareholders' equity17,73117,75415,808
Total common shares outstanding2,4522,4522,457
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.